share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144：拟议出售证券
SEC announcement ·  03/11 10:57
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 03/11/2024, as per the latest filing. These shares, acquired on 10/07/2022 as part of a restricted stock vesting and considered compensation, have an aggregate market value of $4,721.92. This transaction follows a series of sales over the past three months, where a total of 242,048 shares were sold for gross proceeds of $341,724.16. The notice of the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 03/11/2024, as per the latest filing. These shares, acquired on 10/07/2022 as part of a restricted stock vesting and considered compensation, have an aggregate market value of $4,721.92. This transaction follows a series of sales over the past three months, where a total of 242,048 shares were sold for gross proceeds of $341,724.16. The notice of the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on 03/14/2023.
最新文件显示，Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年3月11日出售该公司的3,968股A类股票。这些股票于2022年7月10日作为限制性股票归属的一部分收购，被视为补偿，总市值为4,721.92美元。该交易是在过去三个月进行的一系列销售之后进行的，共出售了242,048股股票，总收益为341,724.16美元。计划出售的通知是在出售的同一天提交的，该交易的计划已于2023年3月14日获得通过。
最新文件显示，Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年3月11日出售该公司的3,968股A类股票。这些股票于2022年7月10日作为限制性股票归属的一部分收购，被视为补偿，总市值为4,721.92美元。该交易是在过去三个月进行的一系列销售之后进行的，共出售了242,048股股票，总收益为341,724.16美元。计划出售的通知是在出售的同一天提交的，该交易的计划已于2023年3月14日获得通过。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息